BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $119,000 | -74.2% | 25,000 | -31.1% | 0.01% | -83.7% |
Q2 2014 | $462,000 | +20.3% | 36,261 | 0.0% | 0.04% | +7.5% |
Q1 2014 | $384,000 | +39.1% | 36,261 | 0.0% | 0.04% | +33.3% |
Q4 2013 | $276,000 | +4.5% | 36,261 | 0.0% | 0.03% | -3.2% |
Q3 2013 | $264,000 | +371.4% | 36,261 | 0.0% | 0.03% | +342.9% |
Q2 2013 | $56,000 | – | 36,261 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |